SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SIRT3 promotion reduces resistance to cisplatin in lung cancer by modulating the FOXO3/CDT1 axis

Published:2021-02 Issue:4 Volume:10 Page:1394-1404
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Med

Author:

Cao Yang¹^ORCID,Li Ping²,Wang Haicun¹,Li Lei¹,Li Quanwang³

Affiliation:

1. The Third Department of Medical Oncology the Third People's Hospital of Zhengzhou Zhengzhou P. R. China

2. Medical Department Women & Infants Hospital of Zhengzhou Zhengzhou P. R. China

3. Department of Oncology Dongfang Hospital of Beijing University of Chinese Medicine Beijing P. R. China

Publisher

Wiley

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.3728

Reference25 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

2. Cisplatin-enriching cancer stem cells confer multidrug resistance in non-small cell lung cancer via enhancing TRIB1/HDAC activity

3. Carboplatin versus two doses of cisplatin in combination with gemcitabine in the treatment of advanced non-small-cell lung cancer: Results from a British Thoracic Oncology Group randomised phase III trial

4. RNA interferences targeting the Fanconi anemia/BRCA pathway upstream genes reverse cisplatin resistance in drug-resistant lung cancer cells

5. Inhibition of ATM reverses EMT and decreases metastatic potential of cisplatin-resistant lung cancer cells through JAK/STAT3/PD-L1 pathway

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin, an artemisinin derivative, reverses oxaliplatin resistance in human colorectal cancer cells by regulating the SIRT3/PI3K/AKT signalling pathway.;Investigación Clínica;2024-08-22

2. Emerging role of sirtuins in non‑small cell lung cancer (Review);Oncology Reports;2024-07-30

3. Exploring Sirtuins: New Frontiers in Managing Heart Failure with Preserved Ejection Fraction;International Journal of Molecular Sciences;2024-07-15

4. Unveiling the potential of FOXO3 in lung cancer: From molecular insights to therapeutic prospects;Biomedicine & Pharmacotherapy;2024-07

5. FTO blocks RNA translational activity via the loss of N6‐methyladenosine methylation at 5′ UTR regulated by RBM5 in cisplatin‐resistant NSCLC;Journal of Cellular Physiology;2024-05-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3